Strota/ Newsroom/ 2026-09-29

SANOFI (SANOFI): Regulatory Action

Strota Newsroom · session of 2026-09-29 · 29 Sep 11:09 · SANOFI stock page →

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Receipt o… Historically, regulatory action events have moved SANOFI-type stocks in the bearish direction 55.0% of the next sessions (n=20).

Sanofi India disclosed on September 29 that it had received a show cause notice from the GST authority, reported under the listing rules that require companies to intimate material events to the exchanges. A show cause notice asks a company to explain why a proposed demand should not be enforced; it is not a final determination and not a penalty.

The size of the notice appears in the headline record rather than the filing. Business Standard reported a ₹23.74 crore GST show cause notice against the company three days earlier, while the exchange intimation in the evidence confirms receipt without stating an amount. The two entries also differ in timing, so the notice reported in the press may be the same one or an earlier one.

Events in this category show no clear historical edge. Across 20 past regulatory-action entries that Strota tracks, the average net edge was -0.057% with a win rate of 55.0%, which reads as neutral. That is a base rate across many past events, not a forecast for this company.

The counter also carries a large completed transaction. On 2026-09-24, Hoechst GmbH sold shares worth ₹1,068.20 crore and Sanofi Healthcare India Private Limited bought the same value, a transfer that ETPharma.com described as a 15.2% stake purchase for ₹1,068 crore. The company's valuation figures in the record are a price-to-earnings ratio of 21.84, a price-to-book ratio of 8.56, earnings per share of 140.68, return on equity of 40.3%, a market capitalisation of ₹7,075 crore and a dividend yield of 7.81%. The Nifty closed 0.28% lower. What the record establishes is a notice received and a large share transfer; it does not establish the outcome of the notice.

The catalyst

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Receipt of Show Cause Notice from GST Authority. (filing · NSE)

What the data shows after this event

Across Strota's backtest of past filings, Regulatory Action shows no reliable next-session edge — the move went bearish in about 55.0% of next sessions (net -0.057% after drift and cost, n=20). A base rate, not a forecast for this stock.

SANOFI right now

P/E 21.84. Full SANOFI analysis →

Sources

Keep digging

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.